Nerbutix (Flucloxacillin)

Flucloxacillin, the active ingredient in Nerbutix, is a penicillinase‑resistant penicillin presented as an oral tablet for oral use. It treats bacterial infections that are susceptible to flucloxacillin, including skin and soft‑tissue infections, bone and joint infections, and certain respiratory tract infections, in both adults and children as prescribed under medical supervision.

GNH USA supplies Nerbutix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent product quality, regulatory compliance, and reliable logistics to meet global demand.

Flucloxacillin is indicated for infections caused by susceptible bacteria, primarily targeting Gram‑positive organisms.

- Skin and soft‑tissue infections: reduces bacterial load and promotes healing of cellulitis, impetigo and wound infections. - Bone and joint infections: eradicates Staphylococcus aureus in osteomyelitis and septic arthritis. - Respiratory tract infections: treats pneumonia and bronchitis caused by susceptible strains. - Staphylococcal infections: effective against beta‑lactamase‑producing Staphylococcus aureus.

Flucloxacillin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often occurring after dosing. - Diarrhea: loose stools that may be self‑limiting. - Rash: mild skin erythema or itching. - Headache: transient headache without neurological signs.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with airway swelling, hypotension and shock. - Clostridioides difficile‑associated colitis: severe diarrhea with abdominal pain and fever. - Hepatic dysfunction: jaundice, elevated liver enzymes or hepatitis.

Before prescribing flucloxacillin, clinicians should consider several safety measures. - Allergy assessment: verify no history of hypersensitivity to penicillins or beta‑lactam antibiotics. - Liver monitoring: check baseline liver function and monitor for signs of hepatitis during therapy. - Renal function: adjust dose or monitor closely in patients with impaired renal clearance. - Contraceptive efficacy: advise women using hormonal contraception that flucloxacillin may reduce effectiveness. - Drug interaction review: assess concomitant medications for potential interactions, especially oral contraceptives and anticoagulants. - Store at room temperature: keep below 25 °C in the original packaging, protected from moisture and direct sunlight.

Flucloxacillin can affect the activity of several other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Oral contraceptives: flucloxacillin may induce hepatic enzymes, decreasing contraceptive hormone levels and increasing risk of unintended pregnancy. - Warfarin: may enhance anticoagulant effect, leading to elevated INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Tetracyclines: antagonistic effect may reduce antibacterial activity when co‑administered. - Aminoglycosides: combined nephrotoxic potential warrants renal function monitoring. - NSAIDs: concurrent use may increase risk of renal impairment, especially in dehydrated patients.